Dipna Pharmachem Limited has confirmed through its Registrar and Share Transfer Agent that all securities received for dematerialization by June 30, 2025, were duly processed.

This means the company's shares submitted for conversion from physical to electronic form were confirmed or rejected, and subsequently listed on the exchange.

Physical certificates were cancelled and shareholder records updated within the specified timeframe.

This ensures accurate and efficient management of the company's shareholder base and dematerialized shares, crucial for investor trust and market operations.